Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.BMS-488043 is used for the treatment of immune disorders, infections, and genitourinary disorders, and can be used in the study of HIV infect
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $138 | In Stock | |
5 mg | $340 | In Stock | |
10 mg | $510 | In Stock | |
25 mg | $828 | In Stock | |
50 mg | $1,150 | In Stock | |
100 mg | $1,550 | In Stock | |
500 mg | $2,970 | In Stock |
Description | BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.BMS-488043 is used for the treatment of immune disorders, infections, and genitourinary disorders, and can be used in the study of HIV infect |
Alias | UNII-MKS21EJ435, CHEMBL238103, BMS488043, BMS 488043, BMS 043 |
Molecular Weight | 422.43 |
Formula | C22H22N4O5 |
Cas No. | 452296-83-2 |
Smiles | C(C(=O)N1CCN(C(=O)C2=CC=CC=C2)CC1)(=O)C=3C=4C(=C(OC)N=CC4OC)NC3 |
Relative Density. | 1.363 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (118.36 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.